IO Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IO Biotech and other ETFs, options, and stocks.About IOBT
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.
CEOMai-Britt Zocca
CEOMai-Britt Zocca
Employees80
Employees80
HeadquartersCopenhagen, North Denmark
HeadquartersCopenhagen, North Denmark
Founded2014
Founded2014
Employees80
Employees80
IOBT Key Statistics
Market cap39.48M
Market cap39.48M
Price-Earnings ratio-0.39
Price-Earnings ratio-0.39
Dividend yield—
Dividend yield—
Average volume883.27K
Average volume883.27K
High today$0.5499
High today$0.5499
Low today$0.48
Low today$0.48
Open price$0.52
Open price$0.52
Volume521.07K
Volume521.07K
52 Week high$2.79
52 Week high$2.79
52 Week low$0.3234
52 Week low$0.3234
Stock Snapshot
As of today, IO Biotech(IOBT) shares are valued at $0.51. The company's market cap stands at 39.48M, with a P/E ratio of -0.39.
As of 2026-01-14, IO Biotech(IOBT) stock has fluctuated between $0.48 and $0.55. The current price stands at $0.51, placing the stock +6.5% above today's low and -7.0% off the high.
The IO Biotech(IOBT)'s current trading volume is 521.07K, compared to an average daily volume of 883.27K.
During the past year, IO Biotech(IOBT) stock moved between $0.32 at its lowest and $2.79 at its peak.
During the past year, IO Biotech(IOBT) stock moved between $0.32 at its lowest and $2.79 at its peak.
People also own
Based on the portfolios of people who own IOBT. This list is generated using Robinhood data, and it’s not a recommendation.